Who Buys Glucosamine from India — 197 Importers Behind a $13.3M Market
India's glucosamine import market is served by 197 active buyers who collectively imported $13.3M across 657 shipments. FIDSON HEALTHCARE PLC (NIGERIA) leads with a 13.8% market share, followed by PANBIO PHARM LLC and AL HAMRIA DRUG STORE LLC,. The top 5 buyers together control 47.0% of total import value, reflecting a moderately competitive buyer landscape.
Top Glucosamine Importers — Ranked by Import Value
FIDSON HEALTHCARE PLC (NIGERIA) is the leading glucosamine importer from India, holding a 13.8% share of the $13.3M market across 657 shipments from 197 buyers. The top 5 buyers — FIDSON HEALTHCARE PLC (NIGERIA), PANBIO PHARM LLC (RUSSIA), AL HAMRIA DRUG STORE LLC, (UNITED ARAB EMIRATES), PHARMAZEN MEDICALS PTE LTD., (SINGAPORE), MOVI HEALTH LLC (POLAND) — collectively control 47.0% of total import value.
Top Glucosamine Buyers & Importers
Ranked by import value · 197 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | FIDSON HEALTHCARE PLCNIGERIA ARTHOCARE FORTE CAPLETS (GLUCOSAMINE, CHARTHOCARE FORTEARTHOCARE CAPSULES (GLUCOSAMINE HYDROCHL | $1.8M | 5 | 13.8% |
| 2 | PANBIO PHARM LLCRUSSIA KONDRO NOVA CAPSULES (GLUCOSAMINE SULPHAKONDRO NOVA CAPSULES GLUCOSAMINE SULPHAKONDRO NOVA CAPUSLES GLUCOSAMINE SULPHA | $1.5M | 5 | 11.2% |
| 3 | AL HAMRIA DRUG STORE LLC,UNITED ARAB EMIRATES CARTIFER AV PER TABLET GLUCOSAMINE SULPHARTHOCARE FORTE CAPLETS (GLUCOSAMINE, CHARTHOCARE FORTE | $1.1M | 5 | 8.2% |
| 4 | PHARMAZEN MEDICALS PTE LTD.,SINGAPORE GLUCOSAMINE 500MG CAPSULES (CARTIFLEX 50GLUCOSAMINE 500MG CAPSULES CARTIFLEX 50GLUCOSAMINE 500MG CAPSULES 100X10S NOS | $962.7K | 5 | 7.3% |
| 5 | MOVI HEALTH LLCPOLAND | $868.3K | 5 | 6.6% |
| 6 | PLANET PHARMAFRANCE CARTILAMINE PLUS GLUCOSAMINE AND CHONDRO | $724.8K | 5 | 5.5% |
| 7 | ORGANOSYN LIMITED LLCUKRAINE | $419.3K | 5 | 3.2% |
| 8 | PHARMAZEN MEDICALS PTE LIMITEDSINGAPORE GLUCOSAMINE 500MG CAPSULES (CARTIFLEX 50GLUCOSAMINE 500MG CAPSULES CARTIFLEX 50GLUCOSAMINE 500MG CAPSULES 100X10S NOS | $278.3K | 5 | 2.1% |
| 9 | CLARION MEDICALS LIMITEDNIGERIA ARTHOCARE FORTE CAPLETS (GLUCOSAMINE, CHARTHOCARE FORTEARTHOCARE CAPSULES (GLUCOSAMINE HYDROCHL | $247.3K | 5 | 1.9% |
| 10 | SUED & FARGESA SRLDOMINICAN REPUBLIC DOLOARTRISAR GLUCOSAMINE 500MG+CHONDROTDOLOARTRISAR SOFT GEL CAPSULE | $221.1K | 5 | 1.7% |
| 11 | AVENIERR PHARMA (PVT) LTD,SRI LANKA GLUCOSAMINE SULPHATE POTASSIUM CHLORIDEGLUCOSAMINE CAPSULES 750MG CARTIPLUS -CARTICARE TABLETS (GLUCOSAMINE SULFATE T | $217.5K | 5 | 1.6% |
| 12 | M S PANBIO PHARM LLCRUSSIA CARTIFER AV PER TABLET GLUCOSAMINE SULPHARTHOCARE FORTE CAPLETS (GLUCOSAMINE, CHARTHOCARE FORTE | $191.0K | 5 | 1.4% |
| 13 | M/S PLANET PHARMAFRANCE KONDRO NOVA CAPSULES (GLUCOSAMINE SULPHACARTILAMINE PLUS GLUCOSAMINE AND CHONDROKONDRO NOVA CAPSULES GLUCOSAMINE SULPHA | $183.9K | 5 | 1.4% |
| 14 | COMMERCIAL BANK OF CEYLON PLCSRI LANKA GLUCOSAMINE SULPHATE POTASSIUM CHLORIDEGLUCOSAMINE CAPSULES 750MG CARTIPLUS -CARTICARE TABLETS (GLUCOSAMINE SULFATE T | $179.5K | 5 | 1.4% |
| 15 | PAN BIO PHARM LLCRUSSIA KONDRO NOVA CAPSULES (GLUCOSAMINE SULPHAKONDRO NOVA CAPSULES GLUCOSAMINE SULPHAKONDRO NOVA CAPUSLES GLUCOSAMINE SULPHA | $143.6K | 5 | 1.1% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Glucosamine — and from which countries?
Flow of Glucosamine exports from India: each country's share and the named importers behind the numbers
Glucosamine — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1Nigeria
Nigeria emerges as the first largest importing country, achieving a total trade value of $2.3M through 28 shipments. This represents a market share of 17.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Nigeria has a diverse importer base, with their top importers including:
• FIDSON HEALTHCARE PLC - $1.8M (81.2% of country's total business)
• CLARION MEDICALS LIMITED - $247.3K (11.0% of country's total business)
Key Insight: Nigeria demonstrates strong market positioning with an average shipment value of $80.4K, indicating premium pricing strategy compared to the market average of $20.2K.
Nigeria is a key market for Glucosamine imports, representing 17.0% of total trade value.
2Russia
Russia emerges as the second largest importing country, achieving a total trade value of $2.2M through 40 shipments. This represents a market share of 16.3% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Russia has a diverse importer base, with their top importers including:
• PANBIO PHARM LLC - $1.5M (68.6% of country's total business)
• M S PANBIO PHARM LLC - $191.0K (8.8% of country's total business)
• PAN BIO PHARM LLC - $143.6K (6.6% of country's total business)
Key Insight: Russia demonstrates strong market positioning with an average shipment value of $54.0K, indicating premium pricing strategy compared to the market average of $20.2K.
Russia is a key market for Glucosamine imports, representing 16.3% of total trade value.
3Singapore
Singapore emerges as the third largest importing country, achieving a total trade value of $1.4M through 22 shipments. This represents a market share of 10.3% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Singapore has a diverse importer base, with their top importers including:
• PHARMAZEN MEDICALS PTE LTD., - $962.7K (70.2% of country's total business)
• PHARMAZEN MEDICALS PTE LIMITED - $278.3K (20.3% of country's total business)
Key Insight: Singapore demonstrates strong market positioning with an average shipment value of $62.3K, indicating premium pricing strategy compared to the market average of $20.2K.
Singapore is a key market for Glucosamine imports, representing 10.3% of total trade value.
4France
France emerges as the fourth largest importing country, achieving a total trade value of $1.3M through 38 shipments. This represents a market share of 9.8% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: France has a diverse importer base, with their top importers including:
• PLANET PHARMA - $724.8K (55.7% of country's total business)
• M/S PLANET PHARMA - $183.9K (14.1% of country's total business)
• M SPLANET PHARMA ZAC DU GRAND LAUNAY - $140.3K (10.8% of country's total business)
Key Insight: France demonstrates strong market positioning with an average shipment value of $34.2K, indicating premium pricing strategy compared to the market average of $20.2K.
France is a key market for Glucosamine imports, representing 9.8% of total trade value.
5United Arab Emirates
United Arab Emirates emerges as the fifth largest importing country, achieving a total trade value of $1.2M through 3 shipments. This represents a market share of 8.8% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United Arab Emirates has a diverse importer base, with their top importers including:
• AL HAMRIA DRUG STORE LLC, - $1.1M (93.3% of country's total business)
Key Insight: United Arab Emirates demonstrates strong market positioning with an average shipment value of $387.6K, indicating premium pricing strategy compared to the market average of $20.2K.
United Arab Emirates is a key market for Glucosamine imports, representing 8.8% of total trade value.
Buyer Segment Analysis
TransData Nexus Glucosamine buyer market intelligence
1Buyer Segment Analysis
The buyer landscape for Glucosamine imported from India encompasses several key segments:
1. Distributors: Entities that purchase Glucosamine in bulk to supply to various retailers, pharmacies, and healthcare providers. Their buying behavior typically involves large, regular orders to maintain a steady supply chain. Examples from our data include FIDSON HEALTHCARE PLC (Nigeria) and PANBIO PHARM LLC (Russia).
2. Retail Chains: Large pharmacy or health store chains that import Glucosamine directly to stock their outlets. They often place sizable orders to distribute across multiple locations. AL HAMRIA DRUG STORE LLC (United Arab Emirates) exemplifies this category.
3. Re-exporters: Companies that import Glucosamine with the intent to export it to other markets. Their order patterns can be irregular, depending on demand in their target export destinations. PHARMAZEN MEDICALS PTE LTD. (Singapore) falls into this segment.
4. Contract Manufacturers: Firms that import Glucosamine as a raw material to produce finished pharmaceutical products for other brands or companies. Their purchasing behavior is aligned with production schedules and client demands. MOVI HEALTH LLC (Poland) is an example from our data.
Understanding these segments aids in tailoring marketing strategies and supply chain logistics to meet the specific needs and behaviors of each buyer type.
Country-Specific Import Regulations
TransData Nexus Glucosamine buyer market intelligence
1Country-Specific Import Regulations
Nigeria
1. Drug Regulatory Authority: National Agency for Food and Drug Administration and Control (NAFDAC).
2. Import Registration Process for Glucosamine: Importers must submit a dossier for screening via the NAFDAC Automated Product Administration and Monitoring System (NAPAMS). A separate application is required for each product. NAFDAC emphasizes that no drug shall be imported, sold, or used in Nigeria unless registered in accordance with its regulations. (nafdac.gov.ng)
3. Estimated Timeline for Registration: The registration process for pharmaceutical products is not more than 120 days from acceptance of the application. (nafdac.gov.ng)
4. Import Tariff/Duty for HS 30049099: Specific tariff information for HS code 30049099 is not detailed in the provided sources. Importers should consult the Nigeria Customs Service for the most current tariff rates.
Russia
1. Drug Regulatory Authority: Ministry of Health of the Russian Federation.
2. Import Registration Process for Glucosamine: Importers must obtain a registration certificate from the Ministry of Health, which involves submitting a comprehensive dossier, including clinical trial data and quality documentation.
3. Estimated Timeline for Registration: The registration process can take approximately 12 to 18 months, depending on the completeness of the submitted documentation and the need for additional studies.
4. Import Tariff/Duty for HS 30049099: Import duties for pharmaceuticals under HS code 30049099 are typically around 5%, but importers should verify current rates with Russian customs authorities.
Singapore
1. Drug Regulatory Authority: Health Sciences Authority (HSA).
2. Import Registration Process for Glucosamine: Importers must apply for product registration through the HSA's Pharmaceutical Regulatory Division, providing necessary documentation on product quality, safety, and efficacy.
3. Estimated Timeline for Registration: The registration process can take between 9 to 12 months, depending on the product's risk classification and the completeness of the application.
4. Import Tariff/Duty for HS 30049099: Singapore imposes a Goods and Services Tax (GST) of 7% on imported goods, but most pharmaceuticals, including those under HS code 30049099, are exempt from import duties.
France
1. Drug Regulatory Authority: French National Agency for Medicines and Health Products Safety (ANSM).
2. Import Registration Process for Glucosamine: Importers must obtain a marketing authorization from ANSM, which requires submission of a dossier containing quality, safety, and efficacy data.
3. Estimated Timeline for Registration: The process typically takes 12 to 24 months, depending on the product's complexity and the need for additional data.
4. Import Tariff/Duty for HS 30049099: As a member of the European Union, France applies the EU's Common External Tariff, which generally imposes a 0% duty on pharmaceutical products under HS code 30049099.
United Arab Emirates
1. Drug Regulatory Authority: Ministry of Health and Prevention (MOHAP).
2. Import Registration Process for Glucosamine: Importers must register pharmaceutical products with MOHAP by submitting a comprehensive dossier, including product composition, manufacturing details, and clinical data.
3. Estimated Timeline for Registration: The registration process can take approximately 6 to 12 months, depending on the completeness of the application and the need for additional information.
4. Import Tariff/Duty for HS 30049099: The UAE generally imposes a 5% import duty on pharmaceutical products under HS code 30049099.
Demand Drivers & Market Opportunity
TransData Nexus Glucosamine buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Glucosamine in importing countries is primarily driven by the prevalence of osteoarthritis and other joint-related disorders. According to the World Health Organization (WHO), osteoarthritis affects 9.6% of men and 18.0% of women over 60 years of age globally, leading to significant demand for treatments like Glucosamine.
Government healthcare programs and the expansion of universal health coverage also contribute to increased demand. For instance, Nigeria's National Health Insurance Scheme (NHIS) aims to provide accessible healthcare to all citizens, potentially increasing the consumption of pharmaceuticals, including Glucosamine. Additionally, countries participating in WHO Essential Medicines List procurement and tender-based purchasing systems often include Glucosamine, further driving demand.
Our data indicates that between 2022 and 2026, 197 buyers across 65 countries imported Glucosamine from India, reflecting a broad and growing market opportunity for this product.
Common Questions — Glucosamine Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest glucosamine buyer importing from India?
Based on import volume and value, FIDSON HEALTHCARE PLC (NIGERIA) leads with $1.8M in imports and a 13.8% market share — the highest of any single glucosamine importer. PANBIO PHARM LLC (RUSSIA) and AL HAMRIA DRUG STORE LLC, (UNITED ARAB EMIRATES) are the next largest buyers.
QHow many companies buy glucosamine from India?
There are 197 active glucosamine buyers importing from India, with a combined market of $13.3M across 657 shipments to 65 countries. The top 5 buyers hold 47.0% of total import value, while the remaining 192 buyers handle the other 53.0%.
QWhich countries import the most glucosamine from India?
The top importing countries for glucosamine from India are Nigeria (17.0%), Russia (16.3%), Singapore (10.3%), France (9.8%), United Arab Emirates (8.8%). These markets represent the largest demand centres for Indian pharmaceutical exports of glucosamine, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for glucosamine from India?
The average import transaction value for glucosamine from India is $20.2K, with an average unit price of $5.65 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Glucosamine buyer market intelligence
1Buyer Segment Analysis
The buyer landscape for Glucosamine imported from India encompasses several key segments:
1. Distributors: Entities that purchase Glucosamine in bulk to supply to various retailers, pharmacies, and healthcare providers. Their buying behavior typically involves large, regular orders to maintain a steady supply chain. Examples from our data include FIDSON HEALTHCARE PLC (Nigeria) and PANBIO PHARM LLC (Russia).
2. Retail Chains: Large pharmacy or health store chains that import Glucosamine directly to stock their outlets. They often place sizable orders to distribute across multiple locations. AL HAMRIA DRUG STORE LLC (United Arab Emirates) exemplifies this category.
3. Re-exporters: Companies that import Glucosamine with the intent to export it to other markets. Their order patterns can be irregular, depending on demand in their target export destinations. PHARMAZEN MEDICALS PTE LTD. (Singapore) falls into this segment.
4. Contract Manufacturers: Firms that import Glucosamine as a raw material to produce finished pharmaceutical products for other brands or companies. Their purchasing behavior is aligned with production schedules and client demands. MOVI HEALTH LLC (Poland) is an example from our data.
Understanding these segments aids in tailoring marketing strategies and supply chain logistics to meet the specific needs and behaviors of each buyer type.
Country-Specific Import Regulations
TransData Nexus Glucosamine buyer market intelligence
1Country-Specific Import Regulations
Nigeria
1. Drug Regulatory Authority: National Agency for Food and Drug Administration and Control (NAFDAC).
2. Import Registration Process for Glucosamine: Importers must submit a dossier for screening via the NAFDAC Automated Product Administration and Monitoring System (NAPAMS). A separate application is required for each product. NAFDAC emphasizes that no drug shall be imported, sold, or used in Nigeria unless registered in accordance with its regulations. (nafdac.gov.ng)
3. Estimated Timeline for Registration: The registration process for pharmaceutical products is not more than 120 days from acceptance of the application. (nafdac.gov.ng)
4. Import Tariff/Duty for HS 30049099: Specific tariff information for HS code 30049099 is not detailed in the provided sources. Importers should consult the Nigeria Customs Service for the most current tariff rates.
Russia
1. Drug Regulatory Authority: Ministry of Health of the Russian Federation.
2. Import Registration Process for Glucosamine: Importers must obtain a registration certificate from the Ministry of Health, which involves submitting a comprehensive dossier, including clinical trial data and quality documentation.
3. Estimated Timeline for Registration: The registration process can take approximately 12 to 18 months, depending on the completeness of the submitted documentation and the need for additional studies.
4. Import Tariff/Duty for HS 30049099: Import duties for pharmaceuticals under HS code 30049099 are typically around 5%, but importers should verify current rates with Russian customs authorities.
Singapore
1. Drug Regulatory Authority: Health Sciences Authority (HSA).
2. Import Registration Process for Glucosamine: Importers must apply for product registration through the HSA's Pharmaceutical Regulatory Division, providing necessary documentation on product quality, safety, and efficacy.
3. Estimated Timeline for Registration: The registration process can take between 9 to 12 months, depending on the product's risk classification and the completeness of the application.
4. Import Tariff/Duty for HS 30049099: Singapore imposes a Goods and Services Tax (GST) of 7% on imported goods, but most pharmaceuticals, including those under HS code 30049099, are exempt from import duties.
France
1. Drug Regulatory Authority: French National Agency for Medicines and Health Products Safety (ANSM).
2. Import Registration Process for Glucosamine: Importers must obtain a marketing authorization from ANSM, which requires submission of a dossier containing quality, safety, and efficacy data.
3. Estimated Timeline for Registration: The process typically takes 12 to 24 months, depending on the product's complexity and the need for additional data.
4. Import Tariff/Duty for HS 30049099: As a member of the European Union, France applies the EU's Common External Tariff, which generally imposes a 0% duty on pharmaceutical products under HS code 30049099.
United Arab Emirates
1. Drug Regulatory Authority: Ministry of Health and Prevention (MOHAP).
2. Import Registration Process for Glucosamine: Importers must register pharmaceutical products with MOHAP by submitting a comprehensive dossier, including product composition, manufacturing details, and clinical data.
3. Estimated Timeline for Registration: The registration process can take approximately 6 to 12 months, depending on the completeness of the application and the need for additional information.
4. Import Tariff/Duty for HS 30049099: The UAE generally imposes a 5% import duty on pharmaceutical products under HS code 30049099.
Demand Drivers & Market Opportunity
TransData Nexus Glucosamine buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Glucosamine in importing countries is primarily driven by the prevalence of osteoarthritis and other joint-related disorders. According to the World Health Organization (WHO), osteoarthritis affects 9.6% of men and 18.0% of women over 60 years of age globally, leading to significant demand for treatments like Glucosamine.
Government healthcare programs and the expansion of universal health coverage also contribute to increased demand. For instance, Nigeria's National Health Insurance Scheme (NHIS) aims to provide accessible healthcare to all citizens, potentially increasing the consumption of pharmaceuticals, including Glucosamine. Additionally, countries participating in WHO Essential Medicines List procurement and tender-based purchasing systems often include Glucosamine, further driving demand.
Our data indicates that between 2022 and 2026, 197 buyers across 65 countries imported Glucosamine from India, reflecting a broad and growing market opportunity for this product.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 197 global importers of Glucosamine identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 657 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 65 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
657 Verified Shipments
197 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists